IONS
Ionis Pharmaceuticals Inc
43.90$
-4.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 112.9% | 113.6% | 99.3% | 72.9% | 0.3% | 0.4% | 1.6% | 1.3% | 2.4% | 1.2% | 1.6% | 1.7% | |
| -12.9% | -13.6% | 0.7% | 100.0% | 99.7% | 99.6% | 98.4% | 98.7% | 97.6% | 98.8% | 98.4% | 98.3% | |
| 112.9% | 113.6% | 99.3% | 72.9% | 69.1% | 41.5% | 73.4% | 79.3% | 141.8% | 114.2% | 127.9% | 97.0% | |
| 9.4% | 13.1% | 14.0% | 21.1% | 40.8% | 25.6% | 48.6% | 21.1% | 25.6% | 29.5% | 37.9% | 41.7% | |
| 9.4% | 13.1% | 113.4% | 94.0% | 109.9% | 67.1% | 121.9% | 102.4% | 167.4% | 143.8% | 165.8% | 138.8% | |
| -22.3% | -26.7% | -13.4% | 6.0% | -10.2% | 32.6% | -23.6% | -3.7% | -69.8% | -44.9% | -67.4% | -40.5% | |
| 10.4% | 12.9% | 11.2% | 8.7% | 7.5% | 4.4% | 6.2% | 1.2% | 1.4% | 10.3% | 12.8% | 9.6% | |
| -25.4% | -31.0% | -24.1% | -3.3% | -12.7% | 30.9% | -23.3% | -3.6% | -43.9% | -42.4% | -65.2% | -40.3% | |
| -7.2% | 0.1% | 0.8% | -1.2% | -48.5% | 3.9% | 43.5% | -0.1% | 2.0% | 4.1% | -0.9% | 0.1% | |
| -18.2% | -31.1% | -25.0% | 0.1% | 45.6% | 26.2% | -66.8% | -3.5% | -45.9% | -46.5% | -64.4% | -40.4% | |
| -10.6% | -14.4% | -10.8% | 7.1% | -3.1% | 34.0% | -21.2% | -0.6% | -38.8% | -29.9% | -50.2% | -30.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.